Integra Lifesciences Holdings (IART) Short term Debt (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Short term Debt of $43.6 million for Q2 2026, up 12.5% sequentially from $38.8 million in Q1 2026, and down 92.41% YoY from $574.6 million in Q2 2025.
Integra Lifesciences Holdings (IART) Short term Debt (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Short term Debt for 16 years, with the latest figure at $43.6 million in Q2 2026.
- Quarterly Short term Debt fell 92.41% year-over-year to $43.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $43.6 million (down 92.41% YoY) and the FY2025 annual result came in at $87.8 million, down 84.68% from the prior year.
- Short term Debt climbed to $43.6 million in Q2 2026 per IART's latest filing, from $38.8 million in the prior quarter.
- Over five years, Short term Debt peaked at $574.6 million in Q2 2025 and troughed at $38.8 million in Q3 2025.
- A 5-year average of $192.7 million and a median of $98.6 million in 2023 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2024 and 2026: Short term Debt surged 656.2% in 2024, then tumbled 93.25% in 2026.
- Over 5 years, Short term Debt stood at $104.7 million in 2022, then fell by 14.8% to $89.2 million in 2023, then soared by 542.57% to $573.2 million in 2024, then sank by 84.68% to $87.8 million in 2025, then sank by 50.35% to $43.6 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $43.6 million, $38.8 million, and $87.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.59 Mn |
| Mar 31, 2026 | 38.75 Mn |
| Dec 31, 2025 | 87.80 Mn |
| Sep 30, 2025 | 38.75 Mn |
| Jun 30, 2025 | 574.63 Mn |
| Mar 31, 2025 | 573.90 Mn |
| Dec 31, 2024 | 573.17 Mn |
| Sep 30, 2024 | 572.44 Mn |
| Jun 30, 2024 | 77.70 Mn |
| Mar 31, 2024 | 94.60 Mn |
| Dec 31, 2023 | 89.20 Mn |
| Sep 30, 2023 | 75.70 Mn |
| Jun 30, 2023 | 90.80 Mn |
| Mar 31, 2023 | 102.50 Mn |
| Dec 31, 2022 | 104.70 Mn |
| Sep 30, 2022 | 106.00 Mn |
| Jun 30, 2022 | 112.50 Mn |
| Mar 31, 2022 | 112.00 Mn |
| Dec 31, 2021 | 112.50 Mn |
| Sep 30, 2021 | 111.70 Mn |